Each of the investors will have a board seat in the new company. In AMPL, Enam Securities holds 44.7 per cent, while Jhelum Investment Fund 1 has 19.9 per cent and veteran investor Hemendra Khotari 9.9 per cent share. The Apollo management said that the new entity, which is only the front-end unit of the standalone pharmacy business, is valued around Rs 5.27 billion. If the back-end part is added, the entire pharmacy business will be valued around Rs 50 billion. Executive vice-chairperson of AHEL Shobana Kamineni, who will continue to lead the pharmacy business, told Business Standard that a decision was taken to unlock potential of the pharmacy business and have a sharp focus. The company also decided to enter e-commerce as part of its omni-channel strategy to provide consumers with a choice between online and physical stores.